Patents by Inventor Keiji KOSUGI

Keiji KOSUGI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUND AND COMPOSITION AS PDGF RECEPTOR KINASE INHIBITOR
    Publication number: 20230101484
    Abstract: An object of the present invention is to provide a compound having a PDGF receptor kinase inhibitory activity. Examples of the present invention may include, for example, a compound represented by the following formula [I] or a pharmaceutically acceptable salt thereof, or a solvate thereof. The compound of the present invention has an inhibitory activity against the PDGF receptor kinase. In addition, since the compound of the present invention has an inhibitory activity against the PDGF receptor kinase, it is useful as a therapeutic agent for respiratory diseases, cancers, smooth muscle proliferative diseases, vasoproliferative diseases, autoimmune/inflammatory diseases, metabolic diseases, vasoocclusive diseases, and the like.
    Type: Application
    Filed: December 11, 2020
    Publication date: March 30, 2023
    Applicant: NIPPON SHINYAKU CO., LTD.
    Inventors: Junshi ASADA, Yoshinari HARUTA, Hiroyuki YAKUSHIJI, Toru TANAKA, Kazuya KURAMOTO, Keiji KOSUGI, Chiaki FUCHIKAMI
  • ANTITUMOR DRUG FOR USE IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITOR
    Publication number: 20230040402
    Abstract: The present invention relates to a prophylactic and/or therapeutic agent for cancer containing an mPGES-1 inhibitor as an active ingredient, the agent being useful in combination with an immune checkpoint inhibitor, and the invention has industrial applicability.
    Type: Application
    Filed: December 24, 2020
    Publication date: February 9, 2023
    Applicant: NIPPON SHINYAKU CO., LTD.
    Inventors: Keiji KOSUGI, Toshiyuki MINAMI, Shiho IWASAKI, Itaru YAMAMOTO